Form 4 for CRL Charles River Laboratories
Accepted 2023-08-29 00:00:00 ET · period of report 2023-08-24 · accession 0001127602-23-023362 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-08-29 | 2023-08-24 | CRL | WALLMAN RICHARD F | Dir | P - Purchase | $198.79 | +1,000 | 1,000 | New | +$198.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-24 | P | A | 1,000 | $198.79 | 1,000 | I By Wife | — | — | (F1) The shares were acquired in 4 transactions ranging in price from $198.70 to $198.85. The reporting person will provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares purchased at each separate price. |